# Noland Arbaugh **Entity class:** Concept or analytic term **Type:** Person **Collection:** [[collections/Neurotech|Neurotech]] **Primary source:** [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] ## Definition Noland Arbaugh is identified as the first human recipient in Neuralink's PRIME clinical program, implanted in January 2024. ## Relationships [[wiki/Noland Arbaugh|Noland Arbaugh]] is related to [[wiki/Neuralink|Neuralink]] and [[wiki/N1 Link|N1 Link]] as the first participant described in the source. <!-- BEGIN HUMANIZED RELATIONSHIPS 2026-09-11 --> This entry's documented connections are expressed in its definition and related-work routes, with provenance retained in the source-linked material. <!-- END HUMANIZED RELATIONSHIPS 2026-09-11 --> ## Source route [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[collections/Neurotech|Neurotech]] ## Related Work in the Corpus <!-- BEGIN HUMANIZED CORPUS ROUTES 2026-09-11 --> - In [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], **Neuralink: Operational Clinical Program and Regulatory Trajectory** provides the narrative context for **Noland Arbaugh**: As of late 2025, Neuralink Corporation has transitioned from speculative R&D to an operational clinical program with regulator-visible outcomes. <!-- END HUMANIZED CORPUS ROUTES 2026-09-11 -->